Page last updated: 2024-12-11
n,n'-desoxycarbadox
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N,N'-desoxycarbadox: metabolite of carbadox [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 9568819 |
| SCHEMBL ID | 10596267 |
| MeSH ID | M0128285 |
Synonyms (20)
| Synonym |
|---|
| (2-quinoxalinylmethylene)hydrazinecarboxylic acid methyl ester |
| n,n'-desoxycarbadox |
| carbadox, deoxy- |
| hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester |
| brn 0799004 |
| desoxycarbadox |
| xu4n6mkp8r , |
| unii-xu4n6mkp8r |
| 55456-55-8 |
| 5-24-03-00423 (beilstein handbook reference) |
| n,n'-deoxycarbadox |
| SCHEMBL10596267 |
| methyl 3-(2-quinoxalinylmethylene) carbazate |
| desoxycarbadox, vetranal(tm), analytical standard |
| 1448350-02-4 |
| methyl n-[(e)-quinoxalin-2-ylmethylideneamino]carbamate |
| CS-0129350 |
| HY-136428 |
| hydrazinecarboxylic acid, 2-(2-quinoxalinylmethylene)-, methyl ester |
| AKOS040758193 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (2)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||